A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases
Open Access
- 4 February 2023
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 89, 104456
- https://doi.org/10.1016/j.ebiom.2023.104456
Abstract
No abstract availableKeywords
Funding Information
- BMBF Berlin
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung (FKZ161L0214B, FKZ161L0214C)
This publication has 100 references indexed in Scilit:
- The utility of cerebrospinal fluid analysis in patients with multiple sclerosisNature Reviews Neurology, 2013
- Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapyNature Medicine, 2012
- Aquaporin 4 and neuromyelitis opticaThe Lancet Neurology, 2012
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's DiseasePLOS ONE, 2012
- Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomasNeuro-Oncology, 2011
- Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factorNeuro-Oncology, 2010
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)PLOS ONE, 2010
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrationsNature Biotechnology, 2010
- Validation of Analytic Methods for Biomarkers Used in Drug DevelopmentClinical Cancer Research, 2008
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008